Incannex Healthcare Ltd to Acquire APIRx Pharmaceuticals USA
Incannex Healthcare Limited, a pharmaceutical company developing the unique medicinal cannabis pharmaceutical products and psychedelic medicine therapies for the unmet medical needs announced that, the company is going to acquire the APIRx Pharmaceutical USA, LLC, that are subject to the approval of shareholder under the Rule 7.1 of ASX listing. This acquisition of the APIRx […]
Continue Reading